Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
McKinsey
Queensland Health
US Department of Justice
Chubb
Chinese Patent Office
Moodys
Baxter
Cipla
AstraZeneca

Generated: January 19, 2018

DrugPatentWatch Database Preview

CORZIDE Drug Profile

« Back to Dashboard

When do Corzide patents expire, and what generic alternatives are available?

Corzide is a drug marketed by King Pharms Llc and is included in one NDA.

The generic ingredient in CORZIDE is bendroflumethiazide; nadolol. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the bendroflumethiazide; nadolol profile page.
Drug patent expirations by year for CORZIDE
Pharmacology for CORZIDE

US Patents and Regulatory Information for CORZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
King Pharms Llc CORZIDE bendroflumethiazide; nadolol TABLET;ORAL 018647-001 May 25, 1983 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
King Pharms Llc CORZIDE bendroflumethiazide; nadolol TABLET;ORAL 018647-002 May 25, 1983 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for CORZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
King Pharms Llc CORZIDE bendroflumethiazide; nadolol TABLET;ORAL 018647-001 May 25, 1983 ➤ Subscribe ➤ Subscribe
King Pharms Llc CORZIDE bendroflumethiazide; nadolol TABLET;ORAL 018647-001 May 25, 1983 ➤ Subscribe ➤ Subscribe
King Pharms Llc CORZIDE bendroflumethiazide; nadolol TABLET;ORAL 018647-002 May 25, 1983 ➤ Subscribe ➤ Subscribe
King Pharms Llc CORZIDE bendroflumethiazide; nadolol TABLET;ORAL 018647-002 May 25, 1983 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Baxter
Merck
Cantor Fitzgerald
Colorcon
Fuji
US Department of Justice
QuintilesIMS
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot